Abstract
Background
Nutritional management is important throughout the treatment period for esophageal cancer patients. This study aimed to evaluate the feasibility of percutaneous radiologic gastrostomy (PRG) and to investigate whether PRG can be applied for patients with advanced esophageal cancer.
Methods
In this study, 89 patients (74 men and 15 women) with advanced esophageal cancer underwent PRG using computed tomography and fluoroscopic guidance. These patients were unsuitable candidates for endoscopic intervention because of esophageal stricture. Primary placement of a mushroom-retained gastrostomy catheter was intended. The end points were technical success and complications after PRG as well as clinical outcomes and survival of the patients. These end points also were compared between the pre-chemoradiotherapy (pre-CRT) and post-CRT groups using the Chi square test, Fisher’s exact test, and the Wilcoxon rank sum test. The survival rate was calculated using the Kaplan–Meier method and compared using the log-rank test.
Results
All the patients had a successful PRG. The mushroom-tip gastrostomy catheter was primarily inserted in 77 patients (86.5 %) and finally achieved for all the patients. Complications occurred for 14 patients (15.7 %) including Dindo-Clavien classification grade 3 (1 catheter dislodgement), grade 2 (2 gastric hemorrhages), and grade 1 (7 skin infections and 4 oozing hemorrhages) complications. During the follow-up period (median, 6 months), 60 patients (67.4 %) died, giving a 12-month survival rate of 37.7 %. Gastrostomy removal was more common in the pre-CRT group (P = 0.011). The pre-CRT group had higher survival rates than the post-CRT group (P = 0.021).
Conclusions
Because PRG provided high technical success with limited complications, it can be used for patients with advanced esophageal cancer whose treatment plan involves multimodal therapy.
Similar content being viewed by others
References
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
Kato K, Muro K, Minashi K, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684–90.
Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–21.
Tougeron D, Di Fiore F, Thureau S, et al. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer. 2008;99:1586–92.
van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.
Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–8.
Bower MR, Martin RC II. Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol. 2009;100:82–7.
Han-Geurts IJ, Hop WC, Tran TC, Tilanus HW. Nutritional status as a risk factor in esophageal surgery. Dig Surg. 2006;23:159–63.
Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763–70.
Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995;221:327–38.
Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg. 2003;238:197–202.
Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001;358:1487–92.
Margolis M, Alexander P, Trachiotis GD, Gharagozloo F, Lipman T. Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg. 2003;76:1694–7; discussion 1697–8.
Stockeld D, Fagerberg J, Granstrom L, Backman L. Percutaneous endoscopic gastrostomy for nutrition in patients with oesophageal cancer. Eur J Surg. 2001;167:839–44.
de Baere T, Chapot R, Kuoch V, et al. Percutaneous gastrostomy with fluoroscopic guidance: single-center experience in 500 consecutive cancer patients. Radiology. 1999;210:651–4.
Perona F, Castellazzi G, De Iuliis A, Rizzo L. Percutaneous radiologic gastrostomy: a 12-year series. Gut Liver. 2010;4(Suppl 1):S44–9.
Inaba Y, Yamaura H, Sato Y, et al. Percutaneous radiologic gastrostomy in patients with malignant pharyngoesophageal obstruction. Jpn J Clin Oncol. 2013;43:713–8.
Cantwell CP, Gervais DA, Hahn PF, Mueller PR. Feasibility and safety of infracolic fluoroscopically guided percutaneous radiologic gastrostomy. JVIR J Vasc Intervent Radiol. 2008;19:129–32.
Covarrubias DA, O’Connor OJ, McDermott S, Arellano RS. Radiologic percutaneous gastrostomy: review of potential complications and approach to managing the unexpected outcome. AJR Am J Roentgenol. 2013;200:921–31.
Tsukuda T, Fujita T, Ito K, Yamashita T, Matsunaga N. Percutaneous radiologic gastrostomy using push-type gastrostomy tubes with CT and fluoroscopic guidance. AJR Am J Roentgenol. 2006;186:574–6.
Tanaka T, Arai Y, Inaba Y, et al. Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. Br J Radiol. 2014;87:20140126.
Sobin LH GM, Wittekind CW. TNM classification of malignant tumours. 7th ed. Wiley, New York, 2009.
Teichgraber UK, Streitparth F, Cho CH, Gebauer B, Ricke J, Benter T. Percutaneous push-through gastrostomy by applying a CT-guided gastropexy. JVIR J Vasc Intervent Radiol. 2011;22:1149–52.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
Brown MC. Cancer metastasis at percutaneous endoscopic gastrostomy stomata is related to the hematogenous or lymphatic spread of circulating tumor cells. Am J Gastroenterol. 2000;95:3288–91.
Seo N, Shin JH, Ko GY, et al. Incidence and management of bleeding complications following percutaneous radiologic gastrostomy. Korean J Radiol. 2012;13:174–81.
Sanchez RB, vanSonnenberg E, D’Agostino HB, Goodacre BW, Moyers P, Casola G. CT guidance for percutaneous gastrostomy and gastroenterostomy. Radiology. 1992;184:201–5.
Lyon SM, Haslam PJ, Duke DM, McGrath FP, Lee MJ. De novo placement of button gastrostomy catheters in an adult population: experience in 53 patients. JVIR J Vasc Intervent Radiol. 2003;14:1283–9.
Funaki B, Peirce R, Lorenz J, et al. Comparison of balloon- and mushroom-retained large-bore gastrostomy catheters. AJR Am J Roentgenol. 2001;177:359–62.
Yang Y, Schneider J, Duber C, Pitton MB. Comparison of fluoroscopy-guided pull-type percutaneous radiological gastrostomy (pull-type PRG) with conventional percutaneous radiological gastrostomy (push-type PRG): clinical results in 253 patients. Eur Radiol. 2011;21:2354–61.
Fietkau R, Lewitzki V, Kuhnt T, et al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer. 2013;119:3343–53.
Zhang P, Xi M, Li QQ, et al. The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer. 2014;5:689–95.
Wright GP, Foster SM, Chung MH. Esophagectomy in patients with prior percutaneous endoscopic gastrostomy tube placement. Am J Surg. 2014;207:361–5; discussion 364–5.
Tessier W, Piessen G, Briez N, Boschetto A, Sergent G, Mariette C. Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy. Surg Endosc. 2013;27:633–41.
Disclosures
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sofue, K., Takeuchi, Y., Tsurusaki, M. et al. Value of Percutaneous Radiologic Gastrostomy for Patients with Advanced Esophageal Cancer. Ann Surg Oncol 23, 3623–3631 (2016). https://doi.org/10.1245/s10434-016-5276-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5276-2